Antithrombin (AT) usually refers to antithrombin, a naturally occurring protein that helps control blood clotting. Doctors measure AT when they investigate unusual clotting (thrombosis) or bleeding risks. The test uses a blood sample, typically plasma (the liquid part of blood), and can report either functional activity (how well the protein works) or antigen level (how much protein is present).
Meaning of AT
AT stands for antithrombin, formerly called antithrombin III. Antithrombin acts as an anticoagulant (a substance that prevents excessive clotting) by blocking enzymes in the clotting cascade, especially thrombin and factor Xa. Two main laboratory approaches exist: activity assays that test function and antigen tests that measure the protein amount. Clinicians choose the type based on the clinical question.
What AT measures in your body
The AT test evaluates the blood’s natural anticoagulant system. The activity assay measures how effectively antithrombin in the sample inhibits clotting enzymes. The antigen test measures the concentration of antithrombin protein. Both tests reflect the liver’s ability to produce the protein and the body’s current consumption or loss of it during illness.
Why doctors order the AT test
Clinicians order AT testing when a patient has unexplained or recurrent blood clots, thrombosis at an unusually young age, clotting in unusual sites (like liver or brain veins), or a strong family history of clotting. Doctors also test when patients have liver disease, nephrotic syndrome (a kidney condition), or when they respond poorly to anticoagulant drugs. In some situations, teams test AT before major surgery or when planning certain anticoagulant therapies.
Factors that can affect AT results
Medications such as heparin can alter measured AT activity because heparin binds to antithrombin and changes test dynamics. Acute clotting events can lower AT due to consumption. Liver disease reduces AT production. Loss of protein through the kidneys (nephrotic syndrome) can decrease levels. Pregnancy and estrogen-containing medications may lower AT modestly. Sample handling—delayed processing or improper storage—can also affect results.
Understanding reference ranges
Labs report AT results using either percent of normal activity, units per milliliter, or international units, and reference ranges vary. Many labs consider functional activity roughly 80–120% as normal; antigen results often use similar ranges. Because methods differ, physicians interpret results in the context of the specific lab’s reference values rather than an absolute universal number.
What high or low levels might mean
Low AT activity or antigen suggests increased risk for venous thrombosis. Causes include inherited antithrombin deficiency (congenital) and acquired conditions such as severe liver disease, nephrotic syndrome, or consumption during acute clotting. Two inherited patterns exist: type I (both antigen and activity low) and type II (normal antigen but low activity). High AT levels rarely carry clinical meaning and often reflect lab variability or compensatory responses; clinicians interpret elevated values cautiously.
Related lab abbreviations
- ATIII: another name for antithrombin (antithrombin III)
- PT: prothrombin time, evaluates part of clotting pathway
- aPTT: activated partial thromboplastin time, evaluates another part of clotting pathway
- INR: international normalized ratio, standardizes PT for warfarin monitoring
- D-dimer: a marker for clot breakdown, used to screen for thrombosis
- Fibrinogen: clotting protein measured when bleeding or clotting problems occur
- PC (protein C) and PS (protein S): other natural anticoagulant proteins measured in clotting workups
- LA: lupus anticoagulant, an antibody that can promote clotting
Frequently asked questions (FAQ)
What sample does the test need?
Labs draw blood into a tube that prevents clotting so they can measure plasma antithrombin.
Do I need to fast or stop medications?
Most people do not need to fast. Tell the lab and clinician about anticoagulants and recent heparin exposure because these can affect results.
How long does it take to get results?
Turnaround varies by facility; many hospitals return results within a day, while outpatient labs may take longer.
If my AT is low, what happens next?
Clinicians evaluate for inherited deficiency versus acquired causes. They may order additional tests (antigen vs activity, family testing, liver and kidney tests) and discuss treatment options to reduce clot risk.
Can pregnancy affect the test?
Yes. Pregnancy commonly lowers some anticoagulant proteins; clinicians interpret results with pregnancy status in mind.
Is genetic testing necessary?
Genetic testing for antithrombin deficiency may help in families with strong histories of early or recurrent thrombosis. Doctors decide based on individual risk and family history.
Glossary of key terms
- Antithrombin: A protein that helps prevent blood clots by inhibiting clotting enzymes.
- Antigen test: A lab method that measures how much of a protein exists.
- Activity assay: A test that measures how well a protein performs its function.
- Thrombosis: Formation of a blood clot inside a blood vessel.
- Anticoagulant: A substance that reduces blood clotting.
- Congenital: Present from birth; inherited.
- Acquired: Developed after birth due to illness, medication, or other conditions.
- Consumptive coagulopathy: Excessive use of clotting factors during widespread clotting, lowering levels.
- Nephrotic syndrome: A kidney disorder that causes protein loss in urine.
Understand your health with BloodSense
Lab data become more useful when patients and clinicians interpret them together. Knowing an antithrombin result—its type (activity or antigen), how it compares to the lab’s reference range, and whether medications or medical conditions could affect it—helps guide decisions about further testing, genetic counseling, or treatments that lower clot risk. Use tools that put lab numbers into context to support clearer conversations with healthcare providers.
